Yin Zi, Guo Jia, Wu Tian-Yi, Chen Xiao, Xu Liang-Liang, Lin Si-En, Sun Yun-Xin, Chan Kai-Ming, Ouyang Hongwei, Li Gang
Dr. Li Dak Sum and Yip Yio Chin Center for Stem Cells and Regenerative Medicine, School of Medicine, Zhejiang University, Hangzhou, People's Republic of China Department of Orthopaedics and Traumatology, Faculty of Medicine, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong, People's Republic of China China Orthopedic Regenerative Medicine Group, Hangzhou, People's Republic of China.
Department of Orthopaedics and Traumatology, Faculty of Medicine, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong, People's Republic of China.
Stem Cells Transl Med. 2016 Aug;5(8):1106-16. doi: 10.5966/sctm.2015-0215. Epub 2016 Jun 8.
: Tendon injuries are common and present a clinical challenge, as they often respond poorly to treatment and result in long-term functional impairment. Inferior tendon healing responses are mainly attributed to insufficient or failed tenogenesis. The main objective of this study was to establish an efficient approach to induce tenogenesis of bone marrow-derived mesenchymal stem cells (BMSCs), which are the most common seed cells in tendon tissue engineering. First, representative reported tenogenic growth factors were used as media supplementation to induce BMSC differentiation, and the expression of teno-lineage transcription factors and matrix proteins was compared. We found that transforming growth factor (TGF)-β1 significantly induced teno-lineage-specific gene scleraxis expression and collagen production. TGF-β1 combined with connective tissue growth factor (CTGF) elevated tenomodulin and Egr1 expression at day 7. Hence, a stepwise tenogenic differentiation approach was established by first using TGF-β1 stimulation, followed by combination with CTGF for another 7 days. Gene expression analysis showed that this stepwise protocol initiated and maintained highly efficient tenogenesis of BMSCs. Finally, regarding in situ rat patellar tendon repair, tendons treated with induced tenogenic BMSCs had better structural and mechanical properties than those of the control group, as evidenced by histological scoring, collagen I and tenomodulin immunohistochemical staining, and tendon mechanical testing. Collectively, these findings demonstrate a reliable and practical strategy of inducing tenogenesis of BMSCs for tendon regeneration and may enhance the effectiveness of cell therapy in treating tendon disorders.
The present study investigated the efficiency of representative tenogenic factors on mesenchymal stem cells' tenogenic differentiation and established an optimized stepwise tenogenic differentiation approach to commit tendon lineage differentiation for functional tissue regeneration. The reliable tenogenic differentiation approach for stem cells not only serves as a platform for further studies of underlying molecular mechanisms but also can be used to enhance cell therapy outcome in treating tendon disorders and develop novel therapeutics for tendon injury.
肌腱损伤很常见,是一项临床挑战,因为它们对治疗的反应往往不佳,并导致长期功能障碍。肌腱愈合反应较差主要归因于成腱不足或失败。本研究的主要目的是建立一种有效的方法来诱导骨髓间充质干细胞(BMSC)的成腱,BMSC是肌腱组织工程中最常见的种子细胞。首先,使用代表性的已报道的成腱生长因子作为培养基补充剂来诱导BMSC分化,并比较腱系转录因子和基质蛋白的表达。我们发现转化生长因子(TGF)-β1显著诱导腱系特异性基因硬骨素表达和胶原蛋白产生。TGF-β1与结缔组织生长因子(CTGF)联合使用在第7天提高了肌腱调节蛋白和早期生长反应蛋白1(Egr1)的表达。因此,建立了一种逐步成腱分化方法,首先使用TGF-β1刺激,然后与CTGF联合使用7天。基因表达分析表明,这种逐步方案启动并维持了BMSC的高效成腱。最后,关于大鼠髌腱原位修复,经诱导成腱的BMSC处理的肌腱在结构和力学性能上比对照组更好,组织学评分、I型胶原蛋白和肌腱调节蛋白免疫组化染色以及肌腱力学测试证明了这一点。总的来说,这些发现证明了一种诱导BMSC成腱以促进肌腱再生的可靠且实用的策略,并可能提高细胞治疗肌腱疾病的有效性。
本研究调查了代表性成腱因子对间充质干细胞成腱分化的效率,并建立了一种优化的逐步成腱分化方法,以促使肌腱谱系分化用于功能性组织再生。可靠的干细胞成腱分化方法不仅作为进一步研究潜在分子机制的平台,还可用于提高细胞治疗肌腱疾病的效果,并开发治疗肌腱损伤的新疗法。